Cargando…
Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia
We report a 49-year-old patient suffering from spastic paraplegia with a novel heterozygous mutation and analyzed the levels of heat shock proteins (hsp)-27, dopamine (DA), and its metabolites in their cerebrospinal fluid (CSF). The hsp27 protein concentration in the patient’s CSF was assayed by an...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379220/ https://www.ncbi.nlm.nih.gov/pubmed/37510225 http://dx.doi.org/10.3390/genes14071320 |
_version_ | 1785079960785911808 |
---|---|
author | García-Carmona, Juan Antonio Amores-Iniesta, Joaquín Soler-Usero, José Cerdán-Sánchez, María Navarro-Zaragoza, Javier López-López, María Soria-Torrecillas, Juan José Ballesteros-Arenas, Ainhoa Pérez-Vicente, José Antonio Almela, Pilar |
author_facet | García-Carmona, Juan Antonio Amores-Iniesta, Joaquín Soler-Usero, José Cerdán-Sánchez, María Navarro-Zaragoza, Javier López-López, María Soria-Torrecillas, Juan José Ballesteros-Arenas, Ainhoa Pérez-Vicente, José Antonio Almela, Pilar |
author_sort | García-Carmona, Juan Antonio |
collection | PubMed |
description | We report a 49-year-old patient suffering from spastic paraplegia with a novel heterozygous mutation and analyzed the levels of heat shock proteins (hsp)-27, dopamine (DA), and its metabolites in their cerebrospinal fluid (CSF). The hsp27 protein concentration in the patient’s CSF was assayed by an ELISA kit, while DA levels and its metabolites in the CSF, 3,4-dihydroxyphenylacetic acid (DOPAC), Cys-DA, and Cys-DOPA were measured by HPLC. Whole exome sequencing demonstrated SPG-11 c.1951C>T and novel SYNJ1 c.2614G>T mutations, both heterozygous recessive. The patient’s DA and DOPAC levels in their CSF were significantly decreased (53.0 ± 6.92 and 473.3 ± 72.19, p < 0.05, respectively) while no differences were found in their Cys-DA. Nonetheless, Cys-DA/DOPAC ratio (0.213 ± 0.024, p < 0.05) and hsp27 levels (1073.0 ± 136.4, p < 0.05) were significantly higher. To the best of our knowledge, the c.2614G>T SYNJ1 mutation has not been previously reported. Our patient does not produce fully functional spatacsin and synaptojanin-1 proteins. In this line, our results showed decreased DA and DOPAC levels in the patient’s CSF, indicating loss of DAergic neurons. Many factors have been described as being responsible for the increased cys-DA/DOPAC ratio, such as MAO inhibition and decreased antioxidant activity in DAergic neurons which would increase catecholquinones and consequently cysteinyl-catechols. In conclusion, haploinsufficiency of spatacsin and synaptojanin-1 proteins might be the underlying cause of neurodegeneration produced by protein trafficking defects, DA vesicle trafficking/recycling processes, autophagy dysfunction, and cell death leading to hsp27 upregulation as a cellular mechanism of protection and/or to balance impaired protein trafficking. |
format | Online Article Text |
id | pubmed-10379220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103792202023-07-29 Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia García-Carmona, Juan Antonio Amores-Iniesta, Joaquín Soler-Usero, José Cerdán-Sánchez, María Navarro-Zaragoza, Javier López-López, María Soria-Torrecillas, Juan José Ballesteros-Arenas, Ainhoa Pérez-Vicente, José Antonio Almela, Pilar Genes (Basel) Article We report a 49-year-old patient suffering from spastic paraplegia with a novel heterozygous mutation and analyzed the levels of heat shock proteins (hsp)-27, dopamine (DA), and its metabolites in their cerebrospinal fluid (CSF). The hsp27 protein concentration in the patient’s CSF was assayed by an ELISA kit, while DA levels and its metabolites in the CSF, 3,4-dihydroxyphenylacetic acid (DOPAC), Cys-DA, and Cys-DOPA were measured by HPLC. Whole exome sequencing demonstrated SPG-11 c.1951C>T and novel SYNJ1 c.2614G>T mutations, both heterozygous recessive. The patient’s DA and DOPAC levels in their CSF were significantly decreased (53.0 ± 6.92 and 473.3 ± 72.19, p < 0.05, respectively) while no differences were found in their Cys-DA. Nonetheless, Cys-DA/DOPAC ratio (0.213 ± 0.024, p < 0.05) and hsp27 levels (1073.0 ± 136.4, p < 0.05) were significantly higher. To the best of our knowledge, the c.2614G>T SYNJ1 mutation has not been previously reported. Our patient does not produce fully functional spatacsin and synaptojanin-1 proteins. In this line, our results showed decreased DA and DOPAC levels in the patient’s CSF, indicating loss of DAergic neurons. Many factors have been described as being responsible for the increased cys-DA/DOPAC ratio, such as MAO inhibition and decreased antioxidant activity in DAergic neurons which would increase catecholquinones and consequently cysteinyl-catechols. In conclusion, haploinsufficiency of spatacsin and synaptojanin-1 proteins might be the underlying cause of neurodegeneration produced by protein trafficking defects, DA vesicle trafficking/recycling processes, autophagy dysfunction, and cell death leading to hsp27 upregulation as a cellular mechanism of protection and/or to balance impaired protein trafficking. MDPI 2023-06-23 /pmc/articles/PMC10379220/ /pubmed/37510225 http://dx.doi.org/10.3390/genes14071320 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article García-Carmona, Juan Antonio Amores-Iniesta, Joaquín Soler-Usero, José Cerdán-Sánchez, María Navarro-Zaragoza, Javier López-López, María Soria-Torrecillas, Juan José Ballesteros-Arenas, Ainhoa Pérez-Vicente, José Antonio Almela, Pilar Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia |
title | Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia |
title_full | Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia |
title_fullStr | Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia |
title_full_unstemmed | Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia |
title_short | Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia |
title_sort | upregulation of heat-shock protein (hsp)-27 in a patient with heterozygous spg11 c.1951c>t and synj1 c.2614g>t mutations causing clinical spastic paraplegia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379220/ https://www.ncbi.nlm.nih.gov/pubmed/37510225 http://dx.doi.org/10.3390/genes14071320 |
work_keys_str_mv | AT garciacarmonajuanantonio upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT amoresiniestajoaquin upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT soleruserojose upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT cerdansanchezmaria upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT navarrozaragozajavier upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT lopezlopezmaria upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT soriatorrecillasjuanjose upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT ballesterosarenasainhoa upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT perezvicentejoseantonio upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia AT almelapilar upregulationofheatshockproteinhsp27inapatientwithheterozygousspg11c1951ctandsynj1c2614gtmutationscausingclinicalspasticparaplegia |